Literature DB >> 16772929

Fetal and adult fibroblasts have similar TGF-beta-mediated, Smad-dependent signaling pathways.

Amy S Colwell1, Thomas M Krummel, Michael T Longaker, H Peter Lorenz.   

Abstract

BACKGROUND: The scarless fetal skin-healing mechanism is mediated in part by the fibroblast and involves differential expression of transforming growth factor (TGF)-beta isoforms 1 and 3. The authors hypothesized that fetal and adult fibroblasts respond differently to TGF-beta isoform-specific stimulation, which may influence whether wounds scar. Connective tissue growth factor (CTGF), Smad3, and Smad7 are TGF-beta target genes. Expression of these targets was quantitated after TGF-beta1 and -beta3 stimulation of fetal and adult fibroblasts.
METHODS: Primary mouse fibroblast cultures at gestational day 16.5 (E17), 18.5 (E19), and 6 weeks (adult) were stimulated with TGF-beta1 or TGF-beta3. Quantitative polymerase chain reaction was performed for CTGF, Smad3, and Smad7 expression.
RESULTS: CTGF was reduced four-fold in E17 and E19 compared with adult fibroblasts (p < 0.005). After TGF-beta1 stimulation, CTGF expression increased more than 60-fold in both E17 and E19 (p < 0.01), which was three-fold greater than that in adult fibroblasts (p < 0.005). TGF-beta3 induced more than 70-fold, 50-fold, and 20-fold increases in CTGF expression in E17, E19, and adult fibroblasts, respectively (p < 0.01 for each). Both TGF-beta1 and -beta3 decreased Smad3 expression and increased Smad7 expression in each fibroblast type, suggesting that intact TGF-beta-mediated signaling pathways were present.
CONCLUSIONS: Fetal (E17 and E19) fibroblasts have lower CTGF expression compared with adult fibroblasts. However, fetal fibroblasts have larger increases in CTGF expression after TGF-beta1 or -beta3 stimulation. Fetal and adult mouse fibroblasts have similar TGF-beta1 and TGF-beta3 transcriptional regulation of Smad3 and Smad7. This suggests that scarless healing is likely not mediated by different Smad-dependent transcriptional responses to TGF-beta isoforms in the fetal E17 fibroblast.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772929     DOI: 10.1097/01.prs.0000224299.16523.76

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  The Contractile Phenotype of Dermal Fetal Fibroblasts in Scarless Wound Healing.

Authors:  Aron Parekh; Patricia A Hebda
Journal:  Curr Pathobiol Rep       Date:  2017-07-28

2.  Immunocytochemical traits of type IV fibrocytes and their possible relations to cochlear function and pathology.

Authors:  Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2009-03-10

3.  Inhibition of osteogenic differentiation of human mesenchymal stem cells.

Authors:  Eduardo K Moioli; Liu Hong; Jeremy J Mao
Journal:  Wound Repair Regen       Date:  2007 May-Jun       Impact factor: 3.617

4.  A review of fetal scarless healing.

Authors:  K J Rolfe; A O Grobbelaar
Journal:  ISRN Dermatol       Date:  2012-05-17

5.  Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype.

Authors:  Zhong Zheng; Aaron W James; Chenshuang Li; Wenlu Jiang; Joyce Z Wang; Grace X Chang; Kevin S Lee; Feng Chen; Emily A Berthiaume; Yao Chen; Hsin Chuan Pan; Eric C Chen; Weiming Li; Zhihe Zhao; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Signal Transduct Target Ther       Date:  2017-10-13

Review 6.  Fetal wound healing biomarkers.

Authors:  Fernanda Rodrigues Helmo; Juliana Reis Machado; Camila Souza de Oliveira Guimarães; Vicente de Paula Antunes Teixeira; Marlene Antônia dos Reis; Rosana Rosa Miranda Corrêa
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

Review 7.  Small Leucine-Rich Proteoglycans in Skin Wound Healing.

Authors:  Xiaoxiao Pang; Nuo Dong; Zhong Zheng
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

8.  Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.

Authors:  Fanghong Mou; Canglang Mou
Journal:  Med Sci Monit       Date:  2020-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.